Bangladesh has been self sufficient in pharmaceutical products for many years. Around 98% of domestic demand is met by the largely locally owned pharma sector which now exports to 86 countries.
Domestic companies were given a boost by the protectionist Essential Drug policy adopted by the government in 1982. However, they have not stood still, content just to produce cheap generic drugs for the local market, but have competed and innovated to become highly effective at making high-quality branded generics, for one-tenth the cost of Western drugs and 20% cheaper than those made in India.
Although scarcity of drug testing facilities has limited exports, factories adhering to the World Health Organisation’s Good Manufacturing Practices standard have secured accreditation from many countries, including the UK.
The government and the Bangladesh Association of Pharmaceutical Industries (Bapi) and Bangladesh Small and Cottage Industries Corporation (BSCIC), have agreed to start building an Active Pharmaceutical Ingredients (API) Park, on 200 acres in Munshiganj district next month. When completed, this Tk3.3bn project will increase efficiency by producing basic raw materials locally.
Over the years, entrepreneurs have made good use of the support provided to the pharma sector to develop their industry and skills base. The API park can help them further to grow exports and to meet challenges from global patent protection measures that are due to come into force.
The pharmaceutical sector is a good example of how vision and public-private cooperation can help build a competitive industry.